Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.6101
-0.0280 (-4.38%)
Feb 20, 2026, 2:35 PM EST - Market open

MTNB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4347108218272
Market Cap Growth
34.76%-94.48%-56.68%-50.35%-19.56%-26.50%
Enterprise Value
1-53280169217
Last Close Price
0.640.5110.8125.0050.5068.00
PS Ratio
--42.8634.016618.481714.82
PB Ratio
0.580.342.442.964.164.26
P/TBV Ratio
0.620.342.623.074.274.63
EV/Sales Ratio
--29.6224.975133.741367.86
Debt / Equity Ratio
0.360.380.190.110.090.06
Net Debt / Equity Ratio
-0.48-0.58-0.53-0.67-0.86-0.86
Net Debt / EBITDA Ratio
0.330.220.441.021.842.30
Net Debt / FCF Ratio
0.340.280.661.232.903.16
Asset Turnover
--0.030.0600.00
Quick Ratio
3.642.735.256.7111.4116.45
Current Ratio
3.783.015.938.0611.7317.25
Return on Equity (ROE)
-151.68%-180.74%-82.11%-47.12%-40.06%-46.39%
Return on Assets (ROA)
-38.81%-66.77%-42.49%-28.96%-23.37%-27.21%
Return on Capital Employed (ROCE)
-114.60%-202.10%-105.70%-60.70%-43.40%-35.90%
Earnings Yield
-438.43%-934.76%-48.84%-19.36%-10.66%-8.27%
FCF Yield
-225.99%-612.29%-32.99%-18.49%-7.09%-6.40%
Buyback Yield / Dilution
-10.59%-11.98%-0.21%-3.16%-6.75%-35.61%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q